As biologics dominate biopharma pipelines, manufacturing hurdles trip up new launches: report

As biologics have come to supersede small molecules in the biopharma industry’s pipeline, the mounting complexity behind the manufacturing of those products is increasingly putting launches under p As biologics have increasingly superseded small molecules in the biopharma industry’s pipeline, the mounting complexity behind the manufacturing of those products is putting production and launches under pressure. Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Special Report Awards Gala Trending Oncology Supply Chain AI and Machine Learning Awards Outsourcing Awards Innovation Awards Pharma Marketing Awards Resources Podcasts Fierce…

Source: FiercePharma